Adipose‐derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein. Issue 9 (8th April 2021)

• Record Type: Journal Article
• Authors: Chu, Yijing; Zhu, Chengzhan; Wang, Qianqian; Liu, Meixin; Wan, Wei; Zhou, Jun; Han, Rendong; Yang, Jing; Luo, Wenqiang; Liu, Chong; Zhou, Huansheng; Li, Min; Yu, Fengsheng; Ye, Yuanhua
• Is Part Of: Journal of cellular and molecular medicine. Volume 25:Issue 9(2021)
• Page Start: 4434
• Page End: 4443
• Publication Date: 2021-04-08
• Subjects: adipose‐derived mesenchymal stem cells -- ovarian cancer -- PAX8 -- protein stability -- TAZ; Cytology; Medicine; Molecular Biology; Cytologie -- Périodiques; Médecine -- Périodiques; Biologie moléculaire -- Périodiques; Cytology -- Periodicals; Medicine -- Periodicals; Molecular biology -- Periodicals; 611.01805
• DOI: 10.1111/jcmm.16511
• Languages: English
• ISSNs: 1582-1838

Abstract

Abstract: Our previous studies have shown that the Adipose‐derived mesenchymal stem cells (ADSCs) can regulate metastasis and development of ovarian cancer. However, its specific mechanism has yet to be fully revealed. In this study, an RNA‐seq approach was adopted to compare the differences in mRNA levels in ovarian cancer cells being given or not given ADSCs. The mRNA level of paired box 8 (PAX8) changed significantly and was confirmed as an important factor in tumour‐inducing effect of ADSCs. In comparison with the ovarian cancer cells cultured in the common growth medium, those cultured in the medium supplemented with ADSCs showed a significant increase of the PAX8 level. Moreover, the cancer cell growth could be restricted, even in the ADSC‐treated group ( P < .05), by inhibiting PAX8. In addition, an overexpression of PAX8 could elevate the proliferation of ovarian cancer cells. Moreover, Co‐IP assays in ovarian cancer cells revealed that an interaction existed between endogenous PAX8 and TAZ. And the PAX8 levels regulated the degradation of TAZ. The bioluminescence images captured in vivo manifested that the proliferation and the PAX8 expression level in ovarian cancers increased in the ADMSC‐treated group, and the effect of ADSCs in promoting tumours was weakened through inhibiting PAX8. Our findings indicate that the PAX8 expression increment could contribute a role in promoting the ADSC‐induced ovarian cancer cell proliferation through TAZ stability regulation.